Phio Pharmaceuticals Management
How experienced are the management team and are they aligned to shareholders interests?
6.0yrs
Average board tenure
CEO
Geert Cauwenbergh (68 yo)
10.83yrs
Tenure
US$58,300
Compensation
Dr. Geert Cauwenbergh, Ph D., Dr., Med Sc., has been a Director of Phio Pharmaceuticals Corp. (formerly known as RXi Pharmaceuticals Corporation) since April 2012 and as its Interim Principal Executive and...
CEO Compensation Analysis
| Date | Total Comp. | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -US$12m |
| Jun 30 2022 | n/a | n/a | -US$12m |
| Mar 31 2022 | n/a | n/a | -US$13m |
| Dec 31 2021 | US$58k | n/a | -US$13m |
| Sep 30 2021 | n/a | n/a | -US$12m |
| Jun 30 2021 | n/a | n/a | -US$11m |
| Mar 31 2021 | n/a | n/a | -US$10m |
| Dec 31 2020 | US$27k | n/a | -US$9m |
| Sep 30 2020 | n/a | n/a | -US$9m |
| Jun 30 2020 | n/a | n/a | -US$9m |
| Mar 31 2020 | n/a | n/a | -US$9m |
| Dec 31 2019 | US$901k | US$132k | -US$9m |
| Sep 30 2019 | n/a | n/a | -US$8m |
| Jun 30 2019 | n/a | n/a | -US$7m |
| Mar 31 2019 | n/a | n/a | -US$7m |
| Dec 31 2018 | US$610k | US$420k | -US$7m |
| Sep 30 2018 | n/a | n/a | -US$8m |
| Jun 30 2018 | n/a | n/a | -US$9m |
| Mar 31 2018 | n/a | n/a | -US$9m |
| Dec 31 2017 | US$579k | US$416k | -US$12m |
| Sep 30 2017 | n/a | n/a | -US$15m |
| Jun 30 2017 | n/a | n/a | -US$15m |
| Mar 31 2017 | n/a | n/a | -US$14m |
| Dec 31 2016 | US$639k | US$414k | -US$11m |
Compensation vs Market: Geert's total compensation ($USD58.30K) is below average for companies of similar size in the US market ($USD730.59K).
Compensation vs Earnings: Geert's compensation has increased whilst the company is unprofitable.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 10.67yrs | US$78.30k | 0.18% $ 12.7k | |
| Interim Principal Executive & Financial Officer and Director | 10.83yrs | US$58.30k | 0.17% $ 11.8k | |
| Independent Director | 0.83yr | no data | no data | |
| Member of Scientific Advisory Board | 6yrs | no data | no data | |
| Independent Director | 9.83yrs | US$65.80k | 0.076% $ 5.4k | |
| Member of Scientific Advisory Board | 5.75yrs | no data | no data | |
| Member of Scientific Advisory Board | 6yrs | no data | no data | |
| Lead Independent Director | 3.33yrs | US$73.30k | 0.15% $ 10.4k | |
| Independent Director | 5.67yrs | US$58.30k | 0.076% $ 5.4k |
6.0yrs
Average Tenure
69.5yo
Average Age
Experienced Board: PHIO's board of directors are considered experienced (6 years average tenure).